Lymphomas

Most recent

Investigator Commentary on the MAINTAIN study by Dr. Mathias Rummel

At the 2017 ASH Annual Meeting, New Evidence spoke with Dr. Mathias Rummel, Head of the Department of Hematology at the Clinic for Hematology and Medical Oncology at the Justus-Liebig University Hospital, Giessen, Germany, about the results of the MAINTAIN study...

Other

Twitter feed

Video: Dr. Mark Vincent Discusses Outcomes in Pancreatic Adenocarcinoma Patients with Genetic Alterations in DNA Da… https://t.co/35E7MSeX3V
h J R
RT @medoncdoc: CO26. first evidence of survival benefit in MSS patients using immunotherapy. 6.6 mo vs 4.1 mo.#GI19 @CDNCancerTrials great…
h J R
RT @tehfem: Adjuvant HIPEC in CRC at high risk for peritoneal mets No benefit #GI19 https://t.co/tYIw9B3eme
h J R
RT @GillSharlene: How long to optimally wait for resection after neoadjuvant therapy for early stage rectal cancer? Looks like the answer…
h J R
Video: Dr. Winson Cheung on Prognostic Factors Associated with Long-Term Survival in Chemotherapy-Treated Advanced… https://t.co/yBP1srRQkb
h J R